Back to companies

Beacon Therapeutics (USA) Inc: Overview

Beacon Therapeutics (USA) Inc formerly Applied Genetic Technologies Corp, is into the development of eye disease cures. Beacon develops treatments for patients who have diseases caused by broken genes. It offers products such as X-linked retinitis pigmentosa, achromatopsia, bionic sight, age-related macular degeneration, non-syndromic hearing loss and deafness, frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). AGTC offers clinical trials. It focuses in the genetic therapies that can restore visual function in patients. The company also offers ophthalmology development programs and proof-of-concept data in multiple indications. Beacon is headquartered in Alachua, Florida, the US.

Gain a 360-degree view of Beacon Therapeutics (USA) Inc and make more informed decisions for your business Gain a 360-degree view of Beacon Therapeutics (USA) Inc and make more informed decisions for your business Contact Us
Headquarters United States of America

Address Suite #10, 14193 NW 119th Terrace, Alachua, Florida, 32615

Telephone 1 386 4622204

No of Employees 102

Industry Pharmaceuticals and Healthcare

Revenue (2022) $330,000

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Products and Services

Products Services
X-Linked Retinitis Pigmentosa Clinical Trials
Achromatopsia
Non-Syndromic Hearing Loss and Deafness
XYZ
XYZ
XYZ
Understand Beacon Therapeutics (USA) Inc portfolio and identify potential areas for collaboration Understand Beacon Therapeutics (USA) Inc portfolio and identify potential areas for collaboration Contact Us

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Asset Disposal In April, the company sold the CMC team and site in Alachua, Florida, the US to Ascend Advanced Therapies.
2022 Others In November, the company received a takeover offer from Syncona Limited.
2021 Contracts/Agreements In April, the company entered into a licensing agreement with SparingVision SAS to provide its proprietary cone specific promoter technology.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Contact Us
Image for loader

Competitor Comparison

Key Parameters Beacon Therapeutics (USA) Inc International Stem Cell Corp MediciNova Inc Cytodyn Inc Kubota Vision Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Alachua Carlsbad La Jolla Vancouver Seattle
State/Province Florida California California Washington Washington
No. of Employees 102 29 13 12 -
Entity Type Private Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Executives
Name Position Board Since Age
Susan B. Washer Chief Executive Officer; President; Director Executive Board - -
Jonathan I. Lieber Chief Financial Officer Senior Management - -
Jerry Reynolds Chief Accounting Officer; Treasurer Senior Management 2020 -
NadiaWaheed Chief Medical Officer Senior Management - -
Abraham Scaria Chief Scientific Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Beacon Therapeutics (USA) Inc key executives to enhance your sales strategy Gain insight into Beacon Therapeutics (USA) Inc key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code